Overview and Scope
A single-use bioreactor is a bioreactor that has a disposable bag instead of a culture vessel. Single-use bioreactors permit processors to move to the utilization of disposable technologies, including single-use bags, in assembly steps that had been reserved for stainless steel gear.
Sizing and Forecast
The single-use bio reactors market size has grown rapidly in recent years. It will grow from $4.53 billion in 2023 to $5.39 billion in 2024 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to biopharmaceutical industry growth, rapid bioprocess development, regulatory support, high adoption rates of precision medicine, rise in healthcare infrastructure.
The single-use bio reactors market size is expected to see exponential growth in the next few years. It will grow to $11.28 billion in 2028 at a compound annual growth rate (CAGR) of 20.3%. The growth in the forecast period can be attributed to personalized medicine and gene therapies, growing of biopharmaceutical research and development, rising healthcare spending, increasing focus on research and development. Major trends in the forecast period include integration of sensors and analytics, closed-system design, customization and modularity, artificial intelligence (ai) and automation, hybrid facilities.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/singleuse-bioreactors-global-market-report
Segmentation & Regional Insights
The single-use bio reactors market covered in this report is segmented –
1) By Type: Stirred-Tank SUBs, Wave-Induced SUBs, Bubble-Column SUBs, Other Types
2) By Molecule Type: Vaccines, Monoclonal Antibodies, Stem Cells, Recombinant Proteins
3) By Cell Type: Mammalian Cell, Bacteria, Yeast
4) By Application: Research And Development (R&D), Process Development, Bioproduction
5) By End User: Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations (CRO), Academic And Research Institutes, Contract Manufacturing Organizations (CMO)
North America was the largest region in the single use bioreactors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-use bio reactors market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6035&type=smp
Major Driver Impacting Market Growth
Increasing demand for pharmaceutical products is expected to propel the growth of the single-use bioreactor market going forward. Pharmaceutical products refer to medications or drugs that are specifically formulated to diagnose, prevent, treat, or cure diseases or medical conditions in humans or animals. Single-use bioreactors play a pivotal role in pharmaceutical production, especially in the manufacturing of biopharmaceuticals such as antibodies, vaccines, and gene therapies. For instance, in June 2022, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a European trade association representing the pharmaceutical industry, the total pharmaceutical production in Europe accounted for $351 billion (€300,000 million) in 2021, with an increase of approximately 5% from $335.2 billion (€286,697 million) in 2020. Therefore, increasing demand for pharmaceutical products is driving the growth of the single-use bioreactor market.
Key Industry Players
Major companies operating in the single-use bio reactors market include CESCO Bioengineering Co Ltd, PBS Biotech Inc, Solida Biotechnology GmbH, ABEC Inc., Eppendorf AG, Sartorius Stedim Biotech Sa Ltd, Danaher Corporation Ltd, Thermo Fisher Scientific Inc., GE Healthcare, Merck Kgaa (Merck Millipore) Pvt Ltd, Distek Inc, Celltainer Biotech Bv Pvt.Ltd, Getinge AB, Pall Corporation, G&G Technologies Inc, SATAKE MultiMix Corporation, Bio-Age Equipment & Service Pvt.Ltd, Entegris Inc., Avantor Inc., Celartia, Cell Culture Company, Cytiva, Solaris Biotechnology srl., Cellexus International Ltd., Distek Inc., Infors AG, OmniBRx Biotechnologies, Xcellerex Inc., Applikon Biotechnology Inc., BBI-Biotech GmbH
The single-use bio reactors market report table of contents includes:
1. Executive Summary
2. Single-Use Bio Reactors Market Characteristics
3. Single-Use Bio Reactors Market Trends And Strategies
4. Single-Use Bio Reactors Market – Macro Economic Scenario
5. Global Single-Use Bio Reactors Market Size and Growth
…
31. Global Single-Use Bio Reactors Market Competitive Benchmarking
32. Global Single-Use Bio Reactors Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Single-Use Bio Reactors Market
34.Single-Use Bio Reactors Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
